Carlyle Group (CG) director David Rubenstein sells 500,000 shares

Q: How many Carlyle Group (CG) shares did David Rubenstein sell and at what price?

David Rubenstein sold 500,000 shares of Carlyle Group common stock. The reported sale price was $46.68 per share , and the transaction was classified as an open-market or private sale under the Form 4 disclosure.

Q: Did David Rubenstein make a charitable gift of Carlyle Group (CG) shares?

Yes. The Form 4 shows a bona fide charitable donation of 100,000 shares of Carlyle Group common stock by David Rubenstein. A footnote clarifies that this transaction reflects a charitable donation made directly by the reporting person.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Carlyle Group Inc. director David M. Rubenstein reported two transactions in the company’s common stock. He made a bona fide charitable gift of 100,000 shares of Carlyle common stock, with no sale proceeds received for that transfer.

On the same date, he also completed an open-market sale of 500,000 shares of Carlyle common stock at a price of $46.68 per share. After these transactions, Rubenstein directly owns 27,399,644 shares of Carlyle common stock.

Insider Trade Summary

Net Seller: 500,000 shares ($23,340,000)

Net Sell 2 txns

Insider Rubenstein David M.

Role Director

Sold 500,000 shs ($23.34M)

Type	Security	Shares	Price	Value
Gift	Common Stock	100,000	$0.00	--
Sale	Common Stock	500,000	$46.68	$23.34M

Holdings After Transaction: Common Stock — 27,899,644 shares (Direct)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

03/20/2026 - 05:34 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rubenstein David M.

(Last)

(First)

(Middle)

1001 PENNSYLVANIA AVENUE, NW

(Street)

WASHINGTON

DISTRICT OF COLUMBIA

20004

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Carlyle Group Inc. [ CG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/19/2026		G⁽¹⁾		100,000	D	$0	27,899,644	D
Common Stock	03/19/2026		S		500,000	D	$46.68	27,399,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects a charitable donation by the Reporting Person.

Remarks:

	/s/ Anne K. Frederick by power of attorney for David M. Rubenstein	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did David Rubenstein report for Carlyle Group (CG)?

David Rubenstein reported a charitable gift and a sale of Carlyle Group common stock. He gifted 100,000 shares and sold 500,000 shares in an open-market transaction, both on the same date, as reflected in the Form 4 filing.

How many Carlyle Group (CG) shares did David Rubenstein sell and at what price?

David Rubenstein sold 500,000 shares of Carlyle Group common stock. The reported sale price was $46.68 per share, and the transaction was classified as an open-market or private sale under the Form 4 disclosure.

Did David Rubenstein make a charitable gift of Carlyle Group (CG) shares?

Yes. The Form 4 shows a bona fide charitable donation of 100,000 shares of Carlyle Group common stock by David Rubenstein. A footnote clarifies that this transaction reflects a charitable donation made directly by the reporting person.

How many Carlyle Group (CG) shares does David Rubenstein own after these transactions?

Following the reported gift and share sale, David Rubenstein directly owns 27,399,644 shares of Carlyle Group common stock. This figure represents his direct holdings as of the date of the Form 4 transactions disclosed in the filing.

Are David Rubenstein’s Carlyle Group (CG) transactions open-market trades or compensation-related?

The Form 4 describes two non-derivative transactions. One is a bona fide gift of 100,000 shares, and the other is an open-market or private sale of 500,000 shares at $46.68 per share, rather than a compensation-related grant or option exercise.